Sie sind hier: Startseite Termine Biosimilars Market Access in the EU and USA
Um unsere Webseite für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies erhalten Sie in unserer Datenschutzerklärung.

Biosimilars Market Access in the EU and USA

05.02.2020 16:39
This biosimilars course addresses the available options for market access in the US and EU, including negotiating with the originator.



von 09:00 bis 17:00




+49 6221 500-680


This course is intended for managing directors, market access managers, legal and IP departments involved in placing a biosimilar product on EU or US markets.

Termin übernehmen

Seminar target:

This course will prepare you for a biosimilar market entry in the EU or USA. It will give you a deeper understanding of the available options for negotiating, licencing and challenging patents, and how to promote your market entry with a distinctive pre-launch communication and appropriate tenders.


- Licencing or challenging patents in the USA

- Negotiating settlement agreements

- First to market requirements for the main EU markets

- Negotiating exclusivity rights for the EU markets

Weitere Informationen über diesen Termin…